1. Home
  2. TRDA vs ELMD Comparison

TRDA vs ELMD Comparison

Compare TRDA & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$6.21

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Logo Electromed Inc.

ELMD

Electromed Inc.

HOLD

Current Price

$28.13

Market Cap

326.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
ELMD
Founded
2016
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.3M
326.9M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
TRDA
ELMD
Price
$6.21
$28.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$21.00
★ $36.00
AVG Volume (30 Days)
★ 290.0K
91.6K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 52.94
EPS
N/A
★ 1.30
Revenue
$25,421,000.00
★ $54,716,000.00
Revenue This Year
$39.97
$15.59
Revenue Next Year
$50.80
$11.51
P/E Ratio
★ N/A
$21.45
Revenue Growth
N/A
★ 13.83
52 Week Low
$5.56
$23.01
52 Week High
$16.45
$47.40

Technical Indicators

Market Signals
Indicator
TRDA
ELMD
Relative Strength Index (RSI) 36.70 35.55
Support Level $5.71 $27.14
Resistance Level $7.89 $29.57
Average True Range (ATR) 0.39 0.87
MACD -0.09 0.63
Stochastic Oscillator 13.85 83.07

Price Performance

Historical Comparison
TRDA
ELMD

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Share on Social Networks: